What if we could treat cancer by going after the genes responsible for the disease? Dana-Farber discovered that lung cancer patients with the EGFR mutation responded dramatically to targeted therapies. The findings launched the era of precision medicine for lung cancer. To learn more, play the video and download the whitepaper.
Pictured above: Pasi Jänne, MD, PhD, Director, Lowe Center for Thoracic Oncology